AMSTERDAM, The Netherlands, Oct. 25, 2017 -- Wright Medical Group N.V. (NASDAQ:WMGI) announced today that it will present at the Jefferies 2017 London Healthcare Conference on Wednesday, November 15, 2017, at the Waldorf Hilton Hotel in London, UK. Julie Tracy, chief communications officer, will present at 8:40 a.m. GMT.
A live audio webcast of the conference presentation, along with the accompanying presentation materials, will be available on Wright’s corporate website at www.wright.com, under the “Investor Relations” link. The audio webcast and accompanying presentation materials will be archived on this site under the “Investor Presentations” link following the conference.
Internet Posting of Information
Wright routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.wright.com. The company encourages investors and potential investors to consult the Wright website regularly for important information about Wright.
About Wright Medical Group N.V.
Wright Medical Group N.V. is a global medical device company focused on extremities and biologics products. The company is committed to delivering innovative, value-added solutions improving quality of life for patients worldwide and is a recognized leader of surgical solutions for the upper extremity (shoulder, elbow, wrist and hand), lower extremity (foot and ankle) and biologics markets, three of the fastest growing segments in orthopedics. For more information about Wright, visit www.wright.com.
Investors & Media:
Julie D. Tracy
Sr. Vice President, Chief Communications Officer
Wright Medical Group N.V.
(901) 290-5817
[email protected]


China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 



